JOLENE LAFRANCE: Open Payments
NPI 1356320600 · WATERTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,444 in 44 payments from 15 companies in 2025. Trend: 2023 $689 · 2024 $856 · 2025 $1,444
Food & beverage: $1,444
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $496 |
| Madrigal Pharmaceuticals | 4 | $368 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Amgen Inc. | 3 | $80 |
| Ascendis Pharma Endocrinology Inc | 3 | $73 |
| Lilly USA, LLC | 2 | $55 |
| Sequel Med Tech, LLC | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Insulet Corporation | 1 | $31 |
| Tandem Diabetes Care, Inc. | 2 | $29 |
Products named: Ozempic, REZDIFFRA, Yorvipath, TEPEZZA, MOUNJARO, TWIIST, Kerendia, Omnipod.
Industry payments across NY — which companies pay providers there.
